Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 3
1994 2
1995 2
1996 2
1997 1
1998 6
1999 2
2000 12
2001 14
2002 16
2003 21
2004 12
2005 18
2006 28
2007 31
2008 27
2009 34
2010 54
2011 57
2012 57
2013 59
2014 56
2015 51
2016 35
2017 32
2018 39
2019 42
2020 32
2021 32
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

699 results

Results by year

Filters applied: . Clear all
Page 1
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.
Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, Clark RE, Cortes JE, Deininger MW, Guilhot F, Hjorth-Hansen H, Hughes TP, Janssen JJWM, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Mayer J, Nicolini F, Niederwieser D, Pane F, Radich JP, Rea D, Richter J, Rosti G, Rousselot P, Saglio G, Saußele S, Soverini S, Steegmann JL, Turkina A, Zaritskey A, Hehlmann R. Hochhaus A, et al. Leukemia. 2020 Apr;34(4):966-984. doi: 10.1038/s41375-020-0776-2. Epub 2020 Mar 3. Leukemia. 2020. PMID: 32127639 Free PMC article. Review.
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.
Wylie AA, Schoepfer J, Jahnke W, Cowan-Jacob SW, Loo A, Furet P, Marzinzik AL, Pelle X, Donovan J, Zhu W, Buonamici S, Hassan AQ, Lombardo F, Iyer V, Palmer M, Berellini G, Dodd S, Thohan S, Bitter H, Branford S, Ross DM, Hughes TP, Petruzzelli L, Vanasse KG, Warmuth M, Hofmann F, Keen NJ, Sellers WR. Wylie AA, et al. Nature. 2017 Mar 30;543(7647):733-737. doi: 10.1038/nature21702. Epub 2017 Mar 22. Nature. 2017. PMID: 28329763
The c-Abl inhibitor in Parkinson disease.
Zhou ZH, Wu YF, Wang XM, Han YZ. Zhou ZH, et al. Neurol Sci. 2017 Apr;38(4):547-552. doi: 10.1007/s10072-016-2808-2. Epub 2017 Jan 11. Neurol Sci. 2017. PMID: 28078567 Review.
Off-Target Effects of BCR-ABL and JAK2 Inhibitors.
Green MR, Newton MD, Fancher KM. Green MR, et al. Am J Clin Oncol. 2016 Feb;39(1):76-84. doi: 10.1097/COC.0000000000000023. Am J Clin Oncol. 2016. PMID: 24351780 Review.
699 results